The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer-Reference-Cited by-同舟云学术

The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer

Published:2021-11 Issue: Volume:38 Page:100880
ISSN:2352-5789
Container-title:Gynecologic Oncology Reports
language:en
Short-container-title:Gynecologic Oncology Reports

Author:

Vultaggio Alessandra,Petrella Maria Cristina,Tomao Federica,Nencini Francesca,Mecheri Valentina,Marini Andrea,Perlato Margherita,Vivarelli Emanuele,De Angelis Claudia,Ferrarini Ilaria,Pillozzi Serena,Matucci Andrea,Antonuzzo Lorenzo

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference18 articles.

1. J. Caiado, L. Venemalm, M.C. Pereira-Santos, L. Costa, M.P. Barbosa, and M. Castells, Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy J Allergy Clin Immunol Pract, 1 (2013), pp. 494–500, 10.1016/j.jaip.2013.06.002.

2. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer;du Bois;J. Natl Cancer Inst.,2003

3. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy;Humbert;Allergy,2005

4. T. Iwamoto, H. Hirai, N. Yamaguchi, N. Kobayashi, H. Sugimoto, T.Tabata, et al. Carboplatin-induced severe hypersensitivity reaction: role of IgE-dependent basophil activation and FcεRI Cancer Sci, 105 (2014), pp. 1472–1479, 10.1111/cas.12538.

5. R. Kristeleit, G.I. Shapiro, H.A. Burris, A.M. Oza, P. LoRusso, M.R. Patel, et al. A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors Clin Cancer Res, 23 (2017), pp. 4095–4106, 10.1158/1078-0432.CCR-16-2796.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adyuvant Use of Omalizumab in Desensitization to Chemotherapeutics: Beyond IgE-Mediated Reactions;Journal of Investigational Allergy and Clinical Immunology;2023-12-11

2. Therapeutical Targets in Allergic Inflammation;Biomedicines;2022-11-09

3. Carboplatin;Reactions Weekly;2022-07